Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria
Advertisement
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
C5a, IL-9, and apo A-IV were identified as potential biomarkers for predicting CSU severity.
Read More
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
Autologous serum skin test positivity was associated with a delayed response to omalizumab treatment in patients with CSU.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
A study highlighted the underutilization of patient-reported outcome measures in the management of AD and CU.
Cailin ConnerChronic Spontaneous Urticaria | April 27, 2024
Disparities in access to omalizumab for patients with CSU significantly impact treatment patterns and health outcomes.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
CSU negatively affects quality of life, and patients with CSU are more likely to have worse sleep.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
Two phase 3 trials of dupilumab in chronic spontaneous urticaria demonstrated significant improvement in urticaria activity.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
According to a meta-analysis, there are statistically significant higher mean total IgE levels in responders to omalizumab th
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
A twofold increase in dosage of desloratadine to 10 mg once daily significantly improves disease severity of CSU.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
The SDown-CSU study emphasized a global need for clear guidance on stepping down chronic spontaneous urticaria treatment.
Cailin ConnerChronic Spontaneous Urticaria | March 14, 2024
A prospective study found that omalizumab and dupilumab effectively managed moderate-to-severe allergic diseases.
Cailin ConnerChronic Spontaneous Urticaria | February 27, 2024
The cross-sectional study found that CSU exhibits similar prevalence in pediatric and adult patients.
Cailin ConnerChronic Spontaneous Urticaria | February 26, 2024
A global survey of allergists and immunologists revealed that 82% favored prescribing omalizumab for CSU.
Cailin ConnerChronic Spontaneous Urticaria | February 23, 2024
A new app developed by urticaria specialists offers a user-friendly platform that allows patients with CSU to track symptoms.
Cailin ConnerChronic Spontaneous Urticaria | February 22, 2024
A study found that serum amyloid A-1 (SAA-1) levels positively correlate with disease activity.
Tamara ThomasChronic Spontaneous Urticaria | February 8, 2024
Patients in the CSU group had hypothyroidism and malignancies, the majority having active disease.
Cailin ConnerChronic Spontaneous Urticaria | February 14, 2024
Patients with comorbid inducible urticaria are younger and experience earlier disease onset and longer duration.
Cailin ConnerChronic Spontaneous Urticaria | February 14, 2024
A study on autoimmune forms of chronic spontaneous urticaria found significant changes in avidity of antibodies.
Cailin ConnerChronic Spontaneous Urticaria | February 14, 2024
Compared with patients with CSU, those with symptomatic dermographism had higher rates of atopic diseases.
Cailin ConnerChronic Spontaneous Urticaria | February 14, 2024
Most patients with chronic spontaneous urticaria treated with H1-antihistamines face inadequate disease control.
Advertisement
Advertisement
Advertisement
Latest News

April 29, 2024